# Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy

> **NCT02478242** · PHASE4 · COMPLETED · sponsor: **Kyungpook National University Hospital** · enrollment: 60 (actual)

## Conditions studied

- Acute Kidney Injury

## Interventions

- **DRUG:** Nafamostat mesilate
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT02478242
- **Lead sponsor:** Kyungpook National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2015-06
- **Final completion:** 2015-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-06-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02478242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02478242, "Trial to Assess the Efficacy and Safety of Nafamostat Mesilate During Continuous Renal Replacement Therapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02478242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*